From the LASSO coefficients (Table 2), the vascular wall biology targets (i.e., F2, ADAM10, and CTSB) all show positive effects, meaning that patients with higher values of these biomarkers are more likely to have delirium. This evidence concerns the gene ADAM10 and delirium.